Based on ONCOMINETM data (https://www.oncomine.org; accessed on 30 August 2021; Supplementary Table S11), DIAPH1, DIAPH3, FMNL2, FHOD1, and INF2 transcripts are frequently upregulated in cancer, whereas those of DIAPH2, DAAM1, DAAM2, FHOD3, FMN2, and FHDC1 are generally downregulated. This evidence concerns the gene DIAPH1 and cancer.